Who can benefit from Malegra FXT in cases of pulmonary hypertension?

Malegra FXT, primarily known for treating erectile dysfunction and premature ejaculation, contains Sildenafil Citrate—a phosphodiesterase type 5 (PDE5) inhibitor.

Sildenafil, the active component, is also effective in managing pulmonary arterial hypertension (PAH) by relaxing blood vessels in the lungs, reducing pulmonary blood pressure, and improving exercise capacity. While Malegra FXT is not specifically approved for PAH, patients with both erectile dysfunction and mild to moderate pulmonary hypertension may experience dual benefits under medical supervision. However, it is essential for such patients to consult a healthcare provider, as the combination of Sildenafil with other medications or underlying conditions may pose health risks.